Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment

Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5

(2020) Yang Liu et al.   Acta Pharmaceutica Sinica B

Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy

(2020) Nancy D. Ebelt et al.   Biomedicines

Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing

(2020) Zhiru Wang et al.   Acta Pharmaceutica Sinica B

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma

(2017) Yvette L. Kasamon et al.   ONCOLOGIST

Two-step enhanced cancer immunotherapy with engineeredSalmonella typhimuriumsecreting heterologous flagellin

(2017) Jin Hai Zheng et al.   Science Translational Medicine

Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism

(2017) Jianxiang Chen et al.   Theranostics

YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis

(2017) Yiting Qiao et al.   Cell Reports

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade

(2016) Haidong Tang et al.   CANCER CELL

Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium

(2016) David C. Binder et al.   OncoImmunology

Reduced Protein Synthesis Fidelity Inhibits Flagellar Biosynthesis and Motility

(2016) Yongqiang Fan et al.   Scientific Reports

Induction of CD4+and CD8+anti-tumor effector T cell responses by bacteria mediated tumor therapy

(2015) Christian Stern et al.   INTERNATIONAL JOURNAL OF CANCER

In vitroprotective effect of lactic acid bacteria onListeria monocytogenesadhesion and invasion of Caco-2 cells

(2015) L.K. Winkelströter et al.   Beneficial Microbes

CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations

(2015) Luis H. Camacho   Cancer Medicine

The application of Toll like receptors for cancer therapy

(2012) Eui Young So et al.   International Journal of Biological Sciences

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anticancer function of polyinosinic-polycytidylic acid

(2011) Yu-sheng Cheng et al.   CANCER BIOLOGY & THERAPY

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

(2010) Richard A Morgan et al.   MOLECULAR THERAPY

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE